z-logo
open-access-imgOpen Access
Acute Hepatitis Induced by Intravesical BCG Therapy: A Rare but Serious Complication
Author(s) -
H. Abid,
Mouna Figuigui,
Sidi Adil Ibrahimi,
M. El Abkari,
Mohamed Mzyiene,
Soufiane Ennaciri,
Ouima Justin Dieudonné Ziba,
M. J. El Fassi,
Layla Tahiri Elousrouti,
Laïla Chbani
Publication year - 2021
Publication title -
case reports in hepatology
Language(s) - English
Resource type - Journals
eISSN - 2090-6587
pISSN - 2090-6595
DOI - 10.1155/2021/4574879
Subject(s) - medicine , immunotherapy , complication , surgery , tuberculosis , hepatitis , pathology , cancer
Bacillus Calmette and Guérin (BCG), widely used as a vaccination to prevent tuberculosis, is also used as immunotherapy, by intrabladder instillation, to treat superficial bladder cancers and prevent recurrence. Complications following instillation of BCG are most often localized reactions, such as cystitis or hematuria. They can more rarely be generalized and potentially severe such as hepatitis, pneumopathies, aortitis, and localization to hematopoietic tissue. We have reported the observation of a 47-year-old patient followed up for a bladder tumor operated for transurethral resection of the bladder, then having benefited from an instillation of BCG therapy complicated by occurrence a week later of an acute hepatitis. The diagnostic time was 2 days, and the outcome was favorable with corticosteroid therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom